Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Seven Fleet Capital Management LP
Form 13F · Q2 2026

Seven Fleet Capital Management LP

CIK 2092021申报日 2026-08-1713F-HR 在 EDGAR 查看原始申报 ↗
$6.1亿
申报组合市值
114
持仓数量
3
Quarters on record
Top 50
持仓数量

Seven Fleet Capital Management LP——持仓

共 114 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1CGON Cg Oncology Inc1.9M+2389.8%$1.3亿22.1%
2TNGX Tango Therapeutics Inc3.2M+543.0%$9566万15.8%
3RVMD Revolution Medicines Inc242,029+199.6%$4533万7.5%
4PHVS Pharvaris N V774,501+348.4%$2678万4.4%
5LQDA Liquidia Corporation256,603+36.6%$2046万3.4%
6ELVN Enliven Therapeutics Inc365,386+122.8%$1854万3.1%
7ABIVAX SA Abivax Sa111,334+158.6%$1484万2.4%
8AVTX Avalo Therapeutics Inc770,765+260.5%$1424万2.4%
9MIRM Mirum Pharmaceuticals Inc110,393—$1292万2.1%
10ASMB Assembly Biosciences Inc433,147+671.5%$1190万2.0%
11IPSC Century Therapeutics Inc4.3M+47.5%$1065万1.8%
12CYTK Cytokinetics Inc118,240+93.0%$1007万1.7%
13TSHA Taysha Gene Therapies Inc1.5M+140.4%$994万1.6%
14MANE Veradermics Inc80,000—$984万1.6%
15AVBP Arrivent Biopharma Inc246,606+390.7%$857万1.4%
16TARS Tarsus Pharmaceuticals Inc117,067+491.2%$791万1.3%
17XNCR Xencor Inc368,305+360.4%$783万1.3%
18ROIV Roivant Sciences Ltd220,126+71.7%$779万1.3%
19DMRA Damora Therapeutics Inc284,430+180.9%$740万1.2%
20AXSM Axsome Therapeutics Inc.28,826+105.1%$706万1.2%
21DFTX Definium Therapeutics Inc148,647+48.8%$699万1.2%
22DNTH Dianthus Therapeutics Inc64,723+19.3%$631万1.0%
23COGT Cogent Biosciences Inc147,510−1.3%$571万0.9%
24ERAS Erasca Inc308,007+38.5%$564万0.9%
25PTGX Protagonist Therapeutics Inc45,400+1035.0%$557万0.9%
26NERV Minerva Neurosciences Inc1.0M+303.0%$556万0.9%
27EDIT Editas Medicine Inc1.3M—$431万0.7%
28CTMX Cytomx Therapeutics Inc.1.1M+192.2%$407万0.7%
29EPRX Eupraxia Pharmaceuticals Inc610,785+40.9%$404万0.7%
30STRO Sutro Biopharma Inc159,118—$379万0.6%
31RLAY Relay Therapeutics Inc178,222−30.9%$333万0.6%
32CLDX Celldex Therapeutics Inc New86,664+195.8%$322万0.5%
33ASND Ascendis Pharma A/S11,869—$317万0.5%
34SGMT Sagimet Biosciences Inc403,545—$312万0.5%
35ZLAB Zai Lab Ltd136,016+74.7%$292万0.5%
36SABS Sab Biotherapeutics Inc736,077+636.1%$287万0.5%
37MDGL Madrigal Pharmaceuticals Inc4,973+46.6%$267万0.4%
38PRAX Praxis Precision Medicines I7,540—$252万0.4%
39RLMD Relmada Therapeutics Inc348,265—$241万0.4%
40AGIO Agios Pharmaceuticals Inc56,900−72.8%$211万0.3%
41XENE Xenon Pharmaceuticals Inc33,300—$208万0.3%
42SVRA Savara Inc309,103+4.5%$190万0.3%
43CCCC C4 Therapeutics Inc381,169+567.8%$178万0.3%
44PCVX Vaxcyte Inc29,800−72.5%$178万0.3%
45CELC Celcuity Inc16,252+170.9%$170万0.3%
46SNDX Syndax Pharmaceuticals Inc77,930—$165万0.3%
47ZNTL Zentalis Pharmaceuticals Inc317,600+188.7%$145万0.2%
48GPCR Structure Therapeutics Inc26,800+197.8%$144万0.2%
49LONA Leonabio Inc154,153−6.4%$142万0.2%
50IDYA Ideaya Biosciences Inc37,865−56.1%$141万0.2%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。